These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1601533)

  • 81. Bioequivalence revisited: non-parametric analysis of two-period cross-over studies.
    Wijnand HP
    Comput Methods Programs Biomed; 1993 Aug; 40(4):249-59. PubMed ID: 8261772
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Equivalence tests for ratio of means in bioequivalence studies under crossover design.
    He Y; Deng Y; You C; Zhou XH
    Stat Methods Med Res; 2022 Jul; 31(7):1405-1419. PubMed ID: 35422161
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [The absence of statistical significance in a clinical trial does not mean therapeutic equivalence].
    Argimon JM
    Med Clin (Barc); 2002 May; 118(18):701-3. PubMed ID: 12042136
    [No Abstract]   [Full Text] [Related]  

  • 84. Sample size calculations for risk equivalence testing in pharmacoepidemiology.
    Tubert-Bitter P; Manfredi R; Lellouch J; Bégaud B
    J Clin Epidemiol; 2000 Dec; 53(12):1268-74. PubMed ID: 11146274
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Estimating equivalence with quantile regression.
    Cade BS
    Ecol Appl; 2011 Jan; 21(1):281-9. PubMed ID: 21516905
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of alternative approaches for difference, noninferiority, and equivalence testing of normal percentiles.
    Shieh G
    BMC Med Res Methodol; 2020 Mar; 20(1):59. PubMed ID: 32169043
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A simple method to estimate sample sizes for safety equivalence studies using inverse sampling.
    Moore N; Tubert-Bitter P; Fourrier A; Bégaud B
    J Clin Epidemiol; 2003 May; 56(5):433-5. PubMed ID: 12812816
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Sensitive and specific determination of the equivalence of absorption rates.
    Endrenyi L; Al-Shaikh P
    Pharm Res; 1995 Dec; 12(12):1856-64. PubMed ID: 8786956
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A new statistical procedure for testing equivalence in two-group comparative bioavailability trials.
    Hauck WW; Anderson S
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):83-91. PubMed ID: 6747820
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The equivalence of the generalized McNemar tests for marginal homogeneity in 2(3) and 3(2) tables.
    Mantel N; Fleiss JL
    Biometrics; 1975 Sep; 31(3):727-9. PubMed ID: 1174626
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Clinical equivalence.
    Bristol DR
    J Biopharm Stat; 1999 Nov; 9(4):549-61. PubMed ID: 10576403
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A new statistical procedure of interval hypothesis testing for bioequivalence studies.
    Ohki T; Suzuki T; Goto S
    Biol Pharm Bull; 1995 Jan; 18(1):192-4. PubMed ID: 7735242
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A note on sample size calculation in bioequivalence trials.
    Hauschke D
    J Pharmacokinet Pharmacodyn; 2002 Feb; 29(1):89-94; author reply 99. PubMed ID: 12194537
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Resampling permutation probability values for Cronbach's alpha.
    Prelog AJ; Berry KJ; Mielke PW
    Percept Mot Skills; 2009 Apr; 108(2):431-8. PubMed ID: 19544948
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Review of methods and criteria for the evaluation of bioequivalence studies.
    Pabst G; Jaeger H
    Eur J Clin Pharmacol; 1990; 38(1):5-10. PubMed ID: 2184041
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Design and analysis of three treatment equivalence trials.
    Wiens BL; Iglewicz B
    Control Clin Trials; 2000 Apr; 21(2):127-37. PubMed ID: 10715510
    [TBL] [Abstract][Full Text] [Related]  

  • 97. How to establish equivalence between treatments: a one-sided clinical trial in pediatric oncology.
    Falk RW
    Stat Med; 1994 Nov; 13(21):2279-80. PubMed ID: 7846426
    [No Abstract]   [Full Text] [Related]  

  • 98. Methods of adjusted comparison of medians.
    Troendle JF; Zhang Z; Mathews ME; Guo J
    Biom J; 2012 Jul; 54(4):481-93. PubMed ID: 22622655
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Methods and applications of percentile estimation.
    Xia Q; Tsong Y; Weng YT
    J Biopharm Stat; 2020 Mar; 30(2):267-276. PubMed ID: 31237475
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Use of a two-sided tolerance interval in the design and evaluation of biosimilarity in clinical studies.
    Chiang C; Chen CT; Hsiao CF
    Pharm Stat; 2021 Jan; 20(1):175-184. PubMed ID: 32869921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.